Drug Profile
CI 1007
Alternative Names: PD 143188Latest Information Update: 07 Oct 2003
Price :
$50
*
At a glance
- Originator Pfizer
- Class Small molecules
- Mechanism of Action Dopamine D2 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Schizophrenia
Most Recent Events
- 07 Oct 2003 No development reported - Phase-II for Schizophrenia in USA (unspecified route)
- 19 Jan 2001 Phase-II clinical trials for Schizophrenia in USA (Unknown route)
- 21 Jun 2000 Warner-Lambert has merged with Pfizer